Table 1.
Baseline experimental and control group demographics
Experimental Group | Control Group | ||
---|---|---|---|
n= | n= | ||
Females | 57 | 53 | |
Males | 15 | 19 | |
Medication Consumption | |||
≤ 4 | 15 | 27 | |
Between 5 and 9 | 35 | 29 | |
> 9 | 19 | 15 | |
psychotropic drug category | 18 | 10 | |
Use of corrective lenses | 58 | 60 | |
Mean (SD) | Mean (SD) | P-value | |
Age | 76.6 (7.0) | 77.2 (8.2) | 0.51 |
Functional Co-morbidity Index | 4.0 (2.1) | 3.9 (2.3) | 0.64 |
Weight (lbs.) | 174.8 (33.5) | 168.8 (37.9) | 0.24 |
Height (inches) | 64.0 (3.6) | 64.0 (4.0) | 0.99 |
Body Mass Index | 29.9 (5.4) | 28.6 (5.4) | 0.12 |
Systolic Blood Pressure (mmHg) | 133 (20) | 131 (15) | 0.52 |
Diastolic Blood Pressure (mmHg) | 76 (10) | 78 (10) | 0.90 |
Heart Rate (beats/minute) | 70 (10) | 71 (10) | 0.78 |
STEADI risk category (0 = low,1 = moderate, 2 = high) |
0.77 (0.7) | 0.71 (0.7) | 0.59 |
SD = Standard deviation